Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III–IV unresectable head and neck cancer: Results of a randomized phase II study;Induktionschemotherapie mit Docetaxel, Cisplatin und 5-Fluorouracil gefolgt von simultaner Chemoradiotherapie oder Chemoradiotherapie allein bei irresekablen Kopf-Hals-Tumoren im Stadium III–IV: Ergebnisse einer randomisierten Phase-II-Studie

Strahlentherapie und Onkologie

Volumn 191, Issue 8, 2015, Pages 635-641

  Takácsi Nagy, Zoltán ^a   Hitre, Erika ^a   Remenár, Éva ^a   Oberna, Ferenc ^b   Polgár, Csaba ^a   Major, Tibor ^a   Gödény, Mária ^a   Fodor, János ^a   Kásler, Miklós ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b BÁCS KISKUN COUNTY TEACHING HOSPITAL   (Hungary)

Author keywords

Chemoradiotherapy; Head and neck cancer; Induction chemotherapy; Randomized trial; TPF

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; ANTINEOPLASTIC AGENT; TAXOID;

ADULT; AGED; ANEMIA; ARTICLE; BONE NECROSIS; CANCER CONTROL; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CHEMORADIOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; ENDOSCOPIC SURGERY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GASTROSTOMY; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INDUCTION CHEMOTHERAPY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVERALL SURVIVAL; PANCYTOPENIA; PERCUTANEOUS ENDOSCOPIC GASTROSTOMA; PHASE 2 CLINICAL TRIAL; POOR GENERAL CONDITION; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SECOND CANCER; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT REFUSAL; TREATMENT RESPONSE; XEROSTOMIA; ADJUVANT THERAPY; ADVERSE EFFECTS; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; OTORHINOLARYNGOLOGIC NEOPLASMS; PATHOLOGY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; TAXOIDS;

EID: 84938419123     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-015-0829-z     Document Type: Article

References (18)

1. Pignon JP, le Maître A, Maillard E et al; MACH-NC Collaborative Group (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4–14
2. Argiris A (2013) Current status and future directions in induction chemotherapy for head and neck cancer. Crit Rev Oncol Hematol 88:57–74
3. Pointreau Y, Garaud P, Chapet S et al (2009) Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101:498–506
4. Posner MR, Hershock DM, Blajman CR et al; TAX 324 Study Group (2007) Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357:1705–1715
5. Blanchard P, Bourhis J, Lacas B et al (2013) Meta-Analysis of Chemotherapy in Head and Neck Cancer, Induction Project, Collaborative Group. Taxane–cisplatin–fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group. J Clin Oncol 31:2854–2860
6. Balermpas P, Bauer C, Fraunholz I et al (2014) Concomitant chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy as definitive, first line treatment of squamous cell carcinoma of the head and neck: a retrospective single center analysis. Strahlenther Onkol 190:256–262
7. Paccagnella A, Ghi MG, Loreggian L et al; Gruppo di Studio Tumori della Testa e del Collo XRP 6976 F/2501 Study (2010) Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. Ann Oncol 21:1515–1522
8. Cohen EEW, Karrison T, Kocherginsky M et al (2012) DeCIDE: a phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN). J Clin Oncol 30(Suppl. abstr):5500
9. Haddad R, O’Neill A, Rabinowits G et al (2013) Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol 14:257–264
10. Hitt R, Grau JJ, López-Pousa A et al (2014) Spanish Head and Neck Cancer Cooperative Group (TTCC). A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer. Ann Oncol 25:216–225
11. Wiggenraad R, Mast M, van Santvoort J et al (2005) ConPas: a 3-D conformal parotid gland-sparing irradiation technique for bilateral neck treatment as an alternative to IMRT. Strahlenther Onkol 18:673–682
12. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors: European Organisation for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216
13. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481
14. Adelstein DJ, Li Y, Adams GL et al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21:92–98
15. Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098
16. Ang KK, Harris J, Garden AS et al (2005) Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99–14. J Clin Oncol 23:3008–3015
17. Brömme JO, Schmücking M, Arnold A et al (2013) Taxane-containing induction chemotherapy followed by definitive chemoradiotherapy. Outcome in patients with locally advanced head and neck cancer. Strahlenther Onkol 189:618–624
18. Greene FL, Page DL, Fleming ID et al (2002) AJCC Cancer Staging Handbook. TNM Classification of Malignant Tumors. Springer-Verlag, New York, pp 27–60